S
SAKAR
vs
B
BSE Sensex 30
Over the past 12 months, SAKAR has significantly outperformed BSE Sensex 30, delivering a return of +91% compared to the BSE Sensex 30's 1% drop.
Stocks Performance
SAKAR vs BSE Sensex 30
Performance Gap
SAKAR vs BSE Sensex 30
Performance By Year
SAKAR vs BSE Sensex 30
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sakar Healthcare Ltd
Glance View
Sakar Healthcare Ltd. engages in the manufacture of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The company went IPO on 2016-10-14. The firm is engaged in the manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectable (SVP) in ampoules, vials & lyophilized injections, oral solid dosages, and research & development of the above products. The Company’s products include Oral - Liquid Syrup & Suspension, Liquid Injectable (SVP)-Vials & Ampoules, Cephalosporin - Dry Powder Injections, Cephalosporin Oral Solid and Lyophilised Injections (In Vials). The firm operates as a contract manufacturer for multinational pharmaceutical companies. The firm serves various countries such as Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering approximately 38 countries. The Company’s subsidiaries include Sakar Oncology Private Limited.
